Clinical Research Directory
Browse clinical research sites, groups, and studies.
JomCare Study - A Harm Reduction Study
Sponsor: University of Connecticut
Summary
Chemsex, the use of psychoactive drugs before or during sexual activity, is a growing public health concern associated with striking increases in HIV, particularly among men who have sex with men (MSM). This study proposes to optimize an app-based just-in-time adaptive intervention, called JomCare, which aims to reduce chemsex risk by delivering tailored support when a person is most likely to be vulnerable to chemsex risk behaviors and receptive to intervention, with the purpose of reducing risk and averting new HIV infections.
Official title: Optimizing a Just-in-Time Adaptive Intervention to Increase Uptake of Chemsex Harm Reduction Services in MSM: A Micro-randomized Trial
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
482
Start Date
2026-04-01
Completion Date
2029-05-30
Last Updated
2026-02-23
Healthy Volunteers
Yes
Conditions
Interventions
JomCare is a smartphone-based just-in-time adaptive intervention (JITAI) for chemsex-related harm reduction.
JomCare is a smartphone-based just-in-time adaptive intervention (JITAI) that uses an EMA-based machine learning (ML) algorithm to anticipate chemsex risk and deliver appropriate chemsex-related harm reduction and HIV prevention services when the risk is detected.
Locations (1)
University of Malaya
Kuala Lumpur, Malaysia